Riskpilot← Back to searchSign inGet full accessHØREKLINIKKEN HELSINGØR ApS
APSActiveCVR 36418109Valby Langgade 88Other human health activities n.e.c. · NACE 8699Est. 2014— employees
Revenue 2025
DKK 156K
+276% vs 2024
EBITDA margin
100.0%
+276% vs 2024
Equity ratio
73.9%
Financial strength
Net profit 2025
DKK 122K
+248% vs 2024
| Revenue | DKK 156K | +276% |
| EBITDA | DKK 156K | +276% |
| Net profit | DKK 122K | +248% |
| Total assets | DKK 233K | +87% |
| Equity | DKK 172K | +102% |
| Employees | — | — |
Legal name
HØREKLINIKKEN HELSINGØR ApS
CVR number
36418109
Legal form
Anpartsselskab
NACE code
8699 · Other human health activities n.e.c.
Founded
28. oktober 2014
Share capital
DKK 50.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening.
Company purpose
Selskabets formål er at drive virksomhed med salg og service af høreapparater og dermed beslægtet virksomhed.
Address
Valby Langgade 88
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -38 | 145 | -4 | 137 | -18 | 143 | 27 | 35 | -37 | 27 | 42 | 156 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -38 | 145 | -4 | 137 | -18 | 143 | 27 | 35 | -37 | 27 | 42 | 156 |
| Depreciation & amort. | 1 | 4 | 4 | -4 | -4 | -3 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -39 | 141 | -8 | 133 | -22 | 140 | 27 | 35 | -37 | 27 | 42 | 156 |
| Net financials | -0 | -2 | 3 | -6 | 8 | -1 | -2 | -1 | -1 | 0 | 0 | 0 |
| Profit before tax | -39 | 139 | -5 | 127 | -14 | 139 | 25 | 34 | -37 | 27 | 42 | 156 |
| Tax | -9 | 32 | -0 | 29 | -0 | 26 | 6 | 7 | -0 | -0 | 7 | 34 |
| Net profit | -31 | 107 | -4 | 97 | -13 | 113 | 19 | 26 | -37 | 27 | 35 | 122 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 65 | 178 | 214 | 317 | 228 | 356 | 310 | 118 | 78 | 87 | 125 | 233 |
| Equity | 19 | 126 | 122 | 220 | 206 | 319 | 179 | 105 | 68 | 77 | 85 | 172 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 46 | 51 | 91 | 97 | 22 | 37 | 132 | 13 | 10 | 10 | 40 | 61 |
| Total debt | 46 | 51 | 91 | 97 | 22 | 37 | 132 | 13 | 10 | 10 | 40 | 61 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20142025
Equity ratio
73.9%
This company
38.2%
Market median
+93% vs market
20142025
Return on equity
70.9%
This company
18.4%
Market median
+285% vs market
20142025
Net profit margin
78.1%
This company
8.1%
Market median
+864% vs market
20142025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
20142025
Debt / equity
0.35×
This company
0.62×
Market median
+44% vs market
20142025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-10-28 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MP Management | Management | 2025 | — | — |
BO Founder | Founder | 2014 | — | — |
NW Management | Management | 2014 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SPECIALLÆGE NIELS WAGNER ApS | Company | 50.0% | 50.0% | 2024 |
AUDITIVA ApS | Company | 33.3% | 33.3% | 2014 |
| Individual | 25.0% | 25.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPECIALLÆGE NIELS WAGNER ApS
HØREKLINIKKEN HELSINGØR ApS Board members of HØREKLINIKKEN HELSINGØR ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Michael Parsberg | Management | 0 companies |
| Bo Ojen | Founder | 0 companies |
| Niels Wagner | Management | 0 companies |